Jan Drappatz

Jan Drappatz

Neurology
5115 Centre Avenue, Hillman Cancer Center
Pittsburgh, PA 15232

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Clinical outcomes after transition from weight-based to fixed-dose glucarpidase for high-dose methotrexate toxicity at a large academic medical center.

Clinical outcomes after transition from weight-based to fixed-dose glucarpidase for high-dose methotrexate toxicity at a large academic medical center.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 09, 2026

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 22, 2026

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 07, 2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 14, 2026

The Effect of Environmental Vulnerability on Family Caregiver Health.

The Effect of Environmental Vulnerability on Family Caregiver Health.

Journal: Oncology nursing forum
Published: March 11, 2026

Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic review.

Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic review.

Journal: Neuro-oncology advances
Published: December 05, 2025

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

Journal: Nature medicine
Published: August 29, 2025

Treatment strategies and innovation for recurrent high-grade glioma.

Treatment strategies and innovation for recurrent high-grade glioma.

Journal: Journal of neuro-oncology
Published: August 15, 2025

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Journal: medRxiv : the preprint server for health sciences
Published: August 08, 2025

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Journal: The oncologist
Published: July 19, 2025

Corticosteroid Use Before Stereotactic Brain Biopsy for Suspected Lymphoma.

Corticosteroid Use Before Stereotactic Brain Biopsy for Suspected Lymphoma.

Journal: Neurosurgery
Published: May 13, 2025

Neuro-oncology Caregiver Intervention Associated With Changes in C-Reactive Protein.

Neuro-oncology Caregiver Intervention Associated With Changes in C-Reactive Protein.

Journal: Cancer nursing
Published: April 23, 2025
Showing 1-12 of 83

Last Updated: 09/26/2026